SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-24-000249
Filing Date
2024-01-26
Accepted
2024-01-26 09:31:27
Documents
10
Period of Report
2024-01-26

Document Format Files

Seq Description Document Type Size
1 6-K zk2430819.htm 6-K 12029
2 EXHIBIT 1.1 exhibit_1-1.htm EX-1.1 224566
3 EXHIBIT 1.2 exhibit_1-2.htm EX-1.2 92727
4 EXHIBIT 1.3 exhibit_1-3.htm EX-1.3 93266
5 EXHIBIT 5.1 exhibit_5-1.htm EX-5.1 8337
6 EXHIBIT 5.2 exhibit_5-2.htm EX-5.2 11885
7 image00001.jpg GRAPHIC 27277
8 image1.jpg GRAPHIC 22319
9 image00003.jpg GRAPHIC 3123
10 image00004.jpg GRAPHIC 1415
  Complete submission text file 0001178913-24-000249.txt   518824
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: 6-K | Act: 34 | File No.: 001-35773 | Film No.: 24564596
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)